Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Stoll

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Arzneimittel-Forschung|May 1, 1988
Investigations on the intraindividual constancy of the ratio of carbamazepine to carbamazepine-10,11-epoxide in manW Fröscher, K D Stoll, G Hildenbrand, et al.
Pharmakopsychiatrie, Neuro-Psychopharmakologie|May 1, 1978
[Clinical trial of mepiprazol in the treatment of neurotic inpatients (author's transl)]N Gonçalves, K D Stoll, E Fähndrich, et al.
Progress in Neuro-Psychopharmacology|January 1, 1977
Videotape training in psychiatric practiceH Heimann, W Obermair, W Boller, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1972
[Changes of Feulgen nuclear reaction in spermatozoa following long-term methotrexate administration. Experimental study]R Milbradt, S Lee, K D Stoll, et al.
Epilepsy Research|March 1, 1992
Hyponatremic coma under oxcarbazepine therapyB J Steinhoff, K D Stoll, S R Stodieck, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2000
Opipramol for the treatment of somatoform disorders results from a placebo-controlled trialH P Volz, H J Möller, I Reimann, et al.
Pharmacopsychiatry|January 1, 1989
Efficacy and tolerability of a new antipsychotic compound (savoxepine): results of a pilot-studyH J Möller, W Kissling, T Dietzfelbinger, et al.
Journal of Clinical Psychopharmacology|February 24, 2001
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated groupH J Möller, H P Volz, I W Reimann, et al.
Fortschritte Der Neurologie-Psychiatrie|January 29, 1999
[Opipramol (Insidon) in the treatment of somatoform disorders]H J Freyberger, H J Grabe, W Maier, et al.
Epilepsia|November 1, 1992
Oxcarbazepine does not affect the anticoagulant activity of warfarinG Krämer, B Tettenborn, P Klosterskov Jensen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Arzneimittel-Forschung|May 1, 1988
Investigations on the intraindividual constancy of the ratio of carbamazepine to carbamazepine-10,11-epoxide in manW Fröscher, K D Stoll, G Hildenbrand, et al.
Pharmakopsychiatrie, Neuro-Psychopharmakologie|May 1, 1978
[Clinical trial of mepiprazol in the treatment of neurotic inpatients (author's transl)]N Gonçalves, K D Stoll, E Fähndrich, et al.
Progress in Neuro-Psychopharmacology|January 1, 1977
Videotape training in psychiatric practiceH Heimann, W Obermair, W Boller, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1972
[Changes of Feulgen nuclear reaction in spermatozoa following long-term methotrexate administration. Experimental study]R Milbradt, S Lee, K D Stoll, et al.
Epilepsy Research|March 1, 1992
Hyponatremic coma under oxcarbazepine therapyB J Steinhoff, K D Stoll, S R Stodieck, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2000
Opipramol for the treatment of somatoform disorders results from a placebo-controlled trialH P Volz, H J Möller, I Reimann, et al.
Pharmacopsychiatry|January 1, 1989
Efficacy and tolerability of a new antipsychotic compound (savoxepine): results of a pilot-studyH J Möller, W Kissling, T Dietzfelbinger, et al.
Journal of Clinical Psychopharmacology|February 24, 2001
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated groupH J Möller, H P Volz, I W Reimann, et al.
Fortschritte Der Neurologie-Psychiatrie|January 29, 1999
[Opipramol (Insidon) in the treatment of somatoform disorders]H J Freyberger, H J Grabe, W Maier, et al.
Epilepsia|November 1, 1992
Oxcarbazepine does not affect the anticoagulant activity of warfarinG Krämer, B Tettenborn, P Klosterskov Jensen, et al.
Pageof 3